Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates.

School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK.
Journal of Applied Microbiology (Impact Factor: 2.39). 06/2006; 100(5):1132-40. DOI: 10.1111/j.1365-2672.2006.02811.x
Source: PubMed

ABSTRACT Triclosan (TCS) exposure of Escherichia coli selects for tolerant clones, mutated in their enoyl-acyl carrier protein reductase (FabI). It has been inferred that this phenomenon is widespread amongst bacterial genera and might be associated with resistance to third party agents.
Ex-situ, low passage isolates of enteric, human axilla, human oral origin and bacteria isolated from a domestic drain, together with selected type cultures were exposed to escalating concentrations of TCS over 10 passages using a gradient plate technique. One fresh faecal isolate of E. coli was included as a positive control. TCS susceptibility was determined for all strains before and after exposure, whilst enteric isolates were additionally assessed for susceptibility towards chlorhexidine, tetracycline, chloramphenicol, nalidixic acid and ciprofloxacin, and the oral isolates towards chlorhexidine, tetracycline and metronidazole.
Triclosan exposure of E. coli markedly decreased TCS susceptibility. TCS susceptibility also decreased for Klebsiella oxytoca, Aranicola proteolyticus and Stenotrophomonas maltophilia. Susceptibility of the remaining 35 strains to TCS and the other test agents remained unchanged.
These data suggest that selection for high level resistance by TCS exposure is not widespread and appears to be confined to certain enteric bacteria, especially E. coli. Change in TCS susceptibility did not affect susceptibility towards chemically unrelated antimicrobials. SIGNIFICANCE AND IMPACT: Acquired high-level TCS resistance is not a widespread phenomenon.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Ten multi-drug resistant Salmonella enterica isolates belonging to ten different serotypes were exposed to increasing sub-inhibitory concentrations of three biocides widely used in food industry facilities (trisodium phosphate, sodium nitrite, or sodium hypochlorite). Cultures were tested, before and after exposure to biocides, against 31 antibiotics of clinical significance by means of a standard disk-diffusion technique (CLSI). Exposed cultures displayed reduced susceptibility to a range of antibiotics, as compared with not exposed cultures. The impact of biocide exposure on reduced susceptibility to antibiotics was dependent on the Salmonella strain and the antibiotic family tested, susceptibility to aminoglycosides and cephalosporins being the most strongly affected. Results in the present study suggest that extensive use of biocides at sub-lethal concentrations could contribute to the emergence of antibiotic resistance in multi-drug resistant Salmonella enterica strains and therefore represent a public health risk. The intra-specific differences observed in antibiotic susceptibility underline the need to screen a wide range of strains.
    Food Control 06/2014; 40:329–334. DOI:10.1016/j.foodcont.2013.11.046 · 2.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Given the breadth and depth of antiseptic use, it is surprising how few large-scale studies have been undertaken into the consequences of their use, particularly in clinical practice. Depending on your point of view, this may either reflect an assurance that reduced susceptibility to antiseptics, and notably whether this confers cross-resistance to systemically administered antimicrobial agents, is not an issue of concern, or relative ignorance about the potential threat. Aim This point/counterpoint review offers a differentiated perspective and possible answers to the question, ‘Should we be worried about reduced susceptibility to disinfectants and antiseptics in healthcare settings?’. Methods This topic was the subject of a debate by MHW (point) and SH (counterpoint) during the SHEA Spring Conference 2013: Advancing healthcare epidemiology and the role of the environment, held in Atlanta, GA, USA on 4th May 2013. This review is a general representation of the main themes presented during the debate, rather than a systematic review of the literature. Findings There are examples of reduced susceptibility to antiseptics in clinical practice; however, to date, there is no strong evidence that reduced susceptibility to antiseptics is a major clinical problem. Given the growing number of potential indications for use of biocidal active ingredients, the potential for emergence of reduced susceptibility remains a concern. Conclusions Changes in the clinical use of antiseptics should be matched with surveillance studies to understand whether there are unintended microbiological or clinical consequences, including the selection of bacterial strains that can survive exposure to antiseptics.
    Journal of Hospital Infection 08/2014; 87(4). DOI:10.1016/j.jhin.2014.04.012 · 2.78 Impact Factor
  • Research in Microbiology 04/2014; DOI:10.1016/j.resmic.2014.03.006 · 2.83 Impact Factor

Full-text (2 Sources)

Available from
Oct 1, 2014